RK
Rovaldo Nguims Kenfack

Publications (2)

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
Article scientifique · 2023
SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
Article scientifique · 2022

Domaines principaux

Sciences de la santé1 Sciences de la vie et biotechnologies1

Statistiques

Consultations5
Téléchargements0